# Psychedelicnewsbreaks Nrx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress On Ketamine NDA And HOPE Clinic Rollup

- URL: https://theranews.net/blog/2026-04-24-psychedelicnewsbreaks-nrx-pharmaceuticals-inc-nasdaq-nrxp-reports-q1-results-hig-740269/
- Published: 2026-04-24
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: menafn
- Original report: https://menafn.com/1111026582/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Reports-Q1-Results-Highlights-Progress-On-Ketamine-NDA-And-HOPE-Clinic-Rollup
- Topics: depression
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> NRx Pharmaceuticals (NASDAQ: NRXP) reported a Q1 2025 net loss of $5.5 million, down from $6.5 million in the same period last year, with operating losses narrowing ...

---
![Psychedelicnewsbreaks Nrx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress On Ketamine NDA And HOPE Clinic Rollup](/uploads/news-images/psychedelicnewsbreaks-nrx-pharmaceuticals-inc-n-20260424170053.jpg)

---
*Originally reported by menafn. [Read more](https://menafn.com/1111026582/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Reports-Q1-Results-Highlights-Progress-On-Ketamine-NDA-And-HOPE-Clinic-Rollup)*

---

*Source: [https://menafn.com/1111026582/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Reports-Q1-Results-Highlights-Progress-On-Ketamine-NDA-And-HOPE-Clinic-Rollup](https://menafn.com/1111026582/Psychedelicnewsbreaks-Nrx-Pharmaceuticals-Inc-NASDAQ-NRXP-Reports-Q1-Results-Highlights-Progress-On-Ketamine-NDA-And-HOPE-Clinic-Rollup)*